Scientists pinpoint new technology for rapid malaria diagnostic

Scientists have been looking for a way to more quickly diagnose malaria in underdeveloped regions. Now, Duke University researchers are moving one step forward with a new technique that uses holographic imaging and deep learning to pinpoint the infection.

A computerized method that relies on computers and light-based holographic scans correctly identified malaria-infected cells in a blood sample, scientists said in results published recently in the journal PLOS ONE. The technique doesn’t require any human intervention and could form the basis for a rapid field test for malaria.

“With this technique, the path is there to be able to process thousands of cells per minute,” Adam Wax, a professor of biomedical engineering at Duke who helped pioneer the technology, said in a statement. "That’s a huge improvement to the 40 minutes it currently takes a field technician to stain, prepare and read a slide to personally look for infection."


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The scientists’ method is based on quantitative phase spectroscopy, a technology that renders holographic images with information on malarial infections in cells.

Researchers also used deep learning to create their technique. Duke engineers fed data on more than 1,000 healthy and diseased cells into a computer, and a program learned how to tell the difference between the two types of cells. A resulting algorithm could spot malaria 97% to 100% of the time.

Wax and the paper’s first author, Han Sang Park, are rolling with the results. The pair started a company, M2 Photonics Innovations, to develop a diagnostic device that uses the new technology.


Suggested Articles

Philips is cementing its commitment to becoming a healthcare technology provider, with plans to split off or sell its consumer appliances division.

A new digital health startup is exiting stealth mode with its advanced, long-lasting patient monitoring device—and touting a quick FDA clearance.

The FDA granted an expanded indication to GT Medical’s GammaTile cancer therapy, broadening its use to newly diagnosed brain cancer patients.